| Nome |
# |
|
Off-label use of ceftaroline fosamil: a systematic review, file e3835323-3ff3-15e8-e053-a505fe0a3de9
|
684
|
|
Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome, file e3835319-c8b7-15e8-e053-a505fe0a3de9
|
525
|
|
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants, file e3835312-3522-15e8-e053-a505fe0a3de9
|
363
|
|
Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study, file e3835324-6761-15e8-e053-a505fe0a3de9
|
340
|
|
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease, file e3835323-6017-15e8-e053-a505fe0a3de9
|
318
|
|
Statins and non-alcoholic fatty liver disease, file e3835323-3eb6-15e8-e053-a505fe0a3de9
|
225
|
|
The challenge of cardiovascular prevention in NAFLD, file e383532c-b13d-15e8-e053-a505fe0a3de9
|
190
|
|
The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease, file e383531f-93fd-15e8-e053-a505fe0a3de9
|
163
|
|
PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress, file e383531d-084a-15e8-e053-a505fe0a3de9
|
138
|
|
Reduced lysosomal acid lipase activity in adult patients with non-alcoholic fatty liver disease, file e383531f-7509-15e8-e053-a505fe0a3de9
|
122
|
|
Oxidative stress: new insights on the association of nonalcoholic fatty liver disease and atherosclerosis, file e3835314-4548-15e8-e053-a505fe0a3de9
|
118
|
|
Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy, file e3835319-be70-15e8-e053-a505fe0a3de9
|
115
|
|
Similar reduction of cholesterol-adjusted Vitamin E serum levels in simple steatosis and non-alcoholic steatohepatitis, file e3835313-cd63-15e8-e053-a505fe0a3de9
|
106
|
|
Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver, file e3835322-d8c0-15e8-e053-a505fe0a3de9
|
106
|
|
Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease, file e3835321-f7c9-15e8-e053-a505fe0a3de9
|
94
|
|
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study, file e383531e-a71f-15e8-e053-a505fe0a3de9
|
91
|
|
Overexpression of the vitronectin v10 subunit in patients with nonalcoholic steatohepatitis: Implications for noninvasive diagnosis of NASH, file e3835319-b704-15e8-e053-a505fe0a3de9
|
90
|
|
Reduced lysosomal acid lipase activity in blood and platelets is associated with nonalcoholic fatty liver disease, file e3835325-eab9-15e8-e053-a505fe0a3de9
|
85
|
|
New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress, file e3835327-fadd-15e8-e053-a505fe0a3de9
|
78
|
|
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?, file e3835323-2191-15e8-e053-a505fe0a3de9
|
76
|
|
Poor adherence to mediterranean diet and serum lipopolysaccharide are associated with oxidative stress in patients with non-alcoholic fatty liver disease, file e3835326-c33e-15e8-e053-a505fe0a3de9
|
64
|
|
HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (NAFLD), file e3835328-e33a-15e8-e053-a505fe0a3de9
|
57
|
|
Nonalcoholic fatty liver disease and the kidney: a review, file e383532d-5e7d-15e8-e053-a505fe0a3de9
|
57
|
|
Is the mediterranean diet the best approach to NAFLD treatment today, file e383532c-bd11-15e8-e053-a505fe0a3de9
|
56
|
|
Sex-related differences in the association between metabolic syndrome and gallstone disease, file e383532a-dac5-15e8-e053-a505fe0a3de9
|
53
|
|
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways, file e383532d-052f-15e8-e053-a505fe0a3de9
|
47
|
|
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. a prospective multicenter cohort study, file e383532a-e492-15e8-e053-a505fe0a3de9
|
43
|
|
Correction to: Reduced lysosomal acid lipase activity in blood and platelets Is associated with nonalcoholic fatty liver disease, file e383532c-be58-15e8-e053-a505fe0a3de9
|
42
|
|
null, file e383532c-fad9-15e8-e053-a505fe0a3de9
|
41
|
|
High compliance to mediterranean diet associates with lower platelet activation and liver collagen deposition in patients with nonalcoholic fatty liver disease, file e383532e-eb5c-15e8-e053-a505fe0a3de9
|
32
|
|
Extra virgin olive oil reduces gut permeability and metabolic endotoxemia in diabetic patients, file 29d3c368-4c26-421e-88fd-e273c7801cdd
|
23
|
|
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis, file e383532e-06bd-15e8-e053-a505fe0a3de9
|
20
|
|
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease, file e383532e-b0eb-15e8-e053-a505fe0a3de9
|
17
|
|
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study, file e383531e-9061-15e8-e053-a505fe0a3de9
|
16
|
|
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review, file e383532e-bb45-15e8-e053-a505fe0a3de9
|
15
|
|
Adherence to mediterranean diet and non-alcoholic fatty liver disease. effect on insulin resistance, file e3835318-6974-15e8-e053-a505fe0a3de9
|
13
|
|
Commentary on "effect of green-mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial", file e383532e-e6c1-15e8-e053-a505fe0a3de9
|
13
|
|
Post-Implantation Syndrome. The impact of different devices for endovascular abdominal aortic aneurysm repair and related etiopathogenetic implications, file e3835328-f069-15e8-e053-a505fe0a3de9
|
11
|
|
Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis, file e3835315-1bda-15e8-e053-a505fe0a3de9
|
9
|
|
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study, file 8f942b40-fc8a-4b1f-96ea-37fd9d5cbd90
|
8
|
|
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study, file e3835316-e9ec-15e8-e053-a505fe0a3de9
|
8
|
|
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study, file e383531a-610a-15e8-e053-a505fe0a3de9
|
8
|
|
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation. the ARAPACIS study, file e3835323-5bb8-15e8-e053-a505fe0a3de9
|
8
|
|
Obstructive Sleep Apnea and the
Metabolic Syndrome: Pathophysiological
and Clinical Evidence, file e3835311-d25a-15e8-e053-a505fe0a3de9
|
7
|
|
Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease, file e3835318-35b1-15e8-e053-a505fe0a3de9
|
6
|
|
Increased liver localization of lipopolysaccharides in human and experimental NAFLD, file e3835328-2a67-15e8-e053-a505fe0a3de9
|
6
|
|
Ridotta attività della lipasi
acida lisosomiale:
un possibile ruolo
patogenetico nella nafld?, file e3835315-4788-15e8-e053-a505fe0a3de9
|
5
|
|
Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose, file e3835318-38af-15e8-e053-a505fe0a3de9
|
5
|
|
Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage, file e3835318-8f1c-15e8-e053-a505fe0a3de9
|
5
|
|
Effects of dark chocolate on endothelial function in patients with non-alcoholic steatohepatitis, file e3835319-ba8f-15e8-e053-a505fe0a3de9
|
5
|
|
Incidence of post-implantation syndrome with different endovascular aortic aneurysm repair modalities and devices and related etiopathogenetic implications, file e3835324-5d45-15e8-e053-a505fe0a3de9
|
5
|
|
Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment, file e3835312-0f29-15e8-e053-a505fe0a3de9
|
4
|
|
Modern approach to the clinical management of non-alcoholic fatty liver disease, file e3835312-6480-15e8-e053-a505fe0a3de9
|
4
|
|
Severity of OSAS, CPAP and cardiovascular events: a follow-up study, file e3835319-fc11-15e8-e053-a505fe0a3de9
|
4
|
|
The intricacies of the Mediterranean diet in NAFLD. Response to Duret et al, file e383531c-c146-15e8-e053-a505fe0a3de9
|
3
|
|
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification, file 95ad3dc9-0173-425c-b111-fe7e690694c7
|
2
|
|
NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease, file e3835311-cdcd-15e8-e053-a505fe0a3de9
|
2
|
|
Relation of Nonalcoholic Fatty Liver Disease and Framingham Risk Score to Flow-Mediated Dilation in Patients With Cardiometabolic Risk Factors, file e383531d-595e-15e8-e053-a505fe0a3de9
|
2
|
|
The post-implantation syndrome(PIS). The impact of different devices for endovascular abdominal aortic aneurysm repair (EVAR) and related etiopathogenetic implications, file e3835325-5f78-15e8-e053-a505fe0a3de9
|
2
|
|
Statin use and mortality in atrial fibrillation. A systematic review and meta-analysis of 100,287 patients, file e383532b-f37b-15e8-e053-a505fe0a3de9
|
2
|
|
Assessment of hepatic fibrosis in MAFLD..a new player in the evaluation of residual cardiovascular risk, file e383532d-35fa-15e8-e053-a505fe0a3de9
|
2
|
|
Open issues in the transition from nafld to mafld. the experience of the plinio study, file ececadfe-c5d9-4942-9414-90c64f8b8033
|
2
|
|
Oxidative stress mediated platelet activation in patients with congenital analbuminemia. Effect of albumin infusion, file cd2eff0b-00cb-46cb-abe7-0ef065326649
|
1
|
|
Obesity and Hypercholesterolemia are Associated with NOX2 Generated Oxidative Stress and Arterial Dysfunction, file e3835312-02d7-15e8-e053-a505fe0a3de9
|
1
|
|
Non-alcoholic fatty liver disease and cardiovascular disease: Epidemiological, clinical and pathophysiological evidences, file e3835312-0f8a-15e8-e053-a505fe0a3de9
|
1
|
|
Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?, file e3835313-cb1c-15e8-e053-a505fe0a3de9
|
1
|
|
The role of nutraceuticals for the treatment of
non-alcoholic fatty liver disease, file e3835314-7efd-15e8-e053-a505fe0a3de9
|
1
|
|
Under-prescription of statins in patients with non-alcoholic fatty liver disease, file e383531c-394f-15e8-e053-a505fe0a3de9
|
1
|
|
Ridotta attività della lipasi
acida lisosomiale:
un possibile ruolo
patogenetico nella nafld?, file e383531e-2d35-15e8-e053-a505fe0a3de9
|
1
|
|
Progressive reduction of blood lysosomal acid lipase activity according to stage of adult chronic liver disease and altered enzymatic cellular distribution in cirrhosis, file e3835322-4c00-15e8-e053-a505fe0a3de9
|
1
|
|
Off-label use of ceftaroline fosamil: a systematic review, file e3835323-85a4-15e8-e053-a505fe0a3de9
|
1
|
|
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation, file e3835324-0f3d-15e8-e053-a505fe0a3de9
|
1
|
|
Prevention and management of type ii diabetes chronic complications. the role of polyphenols (mini-review), file e383532e-ea89-15e8-e053-a505fe0a3de9
|
1
|
| Totale |
4.772 |